ArticleDermatology and therapy2026

Lebrikizumab for the Treatment of Moderate to Severe Atopic Eczema: Real-World Experience from a Tertiary Centre.

Azmeralda Abraheem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.